Physician profile
Ning Fu
NPI 1124224571
$648.30
in general payments reported to CMS, 2019-2025
8 companies · $289 in 2025
The $289 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $19.29 · 2021: $72.88 · 2023: $26.00 · 2024: $14.58 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $330.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $289.48 | 2025 | Indigo System, Penumbra System |
| Bard Peripheral Vascular, INC. | $205.36 | 2019-2021 | |
| Vifor Pharma, INC. | $52.17 | 2019 | |
| Horizon Therapeutics Plc | $26.00 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $23.52 | 2019 | |
| Boston Scientific Corporation | $22.09 | 2021 | |
| Amgen INC. | $15.10 | 2019 | |
| Fresenius USA Marketing, INC. | $14.58 | 2024 | Velphoro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ning Fu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.